Cumberland Pharmaceuticals (CPIX) Times Interest Earned (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Times Interest Earned of -$36.46 for Q1 2026, down 55.87% sequentially from -$23.39 in Q4 2025, and down 562.21% YoY from $7.89 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Times Interest Earned (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Times Interest Earned for 17 years, with the latest figure at -$36.46 in Q1 2026.
- Quarterly Times Interest Earned fell 562.21% year-over-year to -$36.46 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.56 (down 178.49% YoY) and the FY2025 annual result came in at -$5.63, up 47.01% from the prior year.
- Times Interest Earned declined to -$36.46 in Q1 2026 per CPIX's latest filing, from -$23.39 in the prior quarter.
- Over five years, Times Interest Earned peaked at $7.89 in Q1 2025 and troughed at -$39.09 in Q4 2023.
- A 5-year average of -$7.78 and a median of -$1.19 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned plunged 855.44% in 2022, then jumped 1515.84% in 2025.
- Over 5 years, Times Interest Earned stood at -$19.53 in 2022, then slumped by 100.15% to -$39.09 in 2023, then surged by 74.8% to -$9.85 in 2024, then plunged by 137.41% to -$23.39 in 2025, then plunged by 55.87% to -$36.46 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$36.46, -$23.39, and -$0.75 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.01 Mn | 113.14 Mn | - | -4,365.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.45 |
| Mar 31, 2026 | -36.46 |
| Dec 31, 2025 | -23.39 |
| Sep 30, 2025 | -0.75 |
| Jun 30, 2025 | -1.01 |
| Mar 31, 2025 | 7.89 |
| Dec 31, 2024 | -9.85 |
| Sep 30, 2024 | -0.20 |
| Jun 30, 2024 | -0.12 |
| Mar 31, 2024 | -0.56 |
| Dec 31, 2023 | -39.09 |
| Sep 30, 2023 | -0.52 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | -2.52 |
| Dec 31, 2022 | -19.53 |
| Sep 30, 2022 | -1.19 |
| Jun 30, 2022 | -3.46 |
| Mar 31, 2022 | -1.57 |
| Dec 31, 2021 | -156.99 |
| Sep 30, 2021 | -1.11 |